Global Access Diagnostics (GADx), a social enterprise and leading developer of lateral flow and rapid diagnostic technologies, today announced it has expanded the applications of its low-cost, rapid diagnostic test, BotrytisAlert.
Geron’s royalty deal; Minghui’s new VEGF bispecific data
Plus, news about ADC Therapeutics, Celldex and Viracta Therapeutics: Geron inks up to $375M royalty and debt deal: The company now Sign up to read